{"transactions":[{"id":1860302,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T16:49:22.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":25.4,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-23-000116","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000161071723000116/form4.xml","form_type":"4"}},{"id":2225173,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:00:52.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":10192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 16, 2022. The shares underlying the award shall vest in full on the earlier of June 16, 2023 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":10192,"derivative":{"exercise_price":36.79,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10192},"source":{"system":"sec-edgar","filing":"0001209191-22-038559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919122038559/doc4.xml","form_type":"4"}},{"id":2235671,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T18:35:45.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":12.29,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-22-012702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761922012702/doc1.xml","form_type":"4"}},{"id":2444197,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-01-06T01:38:15.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2022."}],"balance_after":6041,"derivative":{"exercise_price":10.38,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":6041},"source":{"system":"sec-edgar","filing":"0000899243-22-001057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924322001057/doc4.xml","form_type":"4"}},{"id":2558726,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":2030,"price":90.7479,"value":184218.237,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $90.53 - $91.07, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1653128,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558725,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":14163,"price":90.082,"value":1275831.366,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $89.47 - $90.44, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1655158,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558724,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":5467,"price":88.8982,"value":486006.4594,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $88.44 - $89.44, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1669321,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558723,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":14751,"price":87.9764,"value":1297739.8764,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $87.43 - $88.43, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1674788,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558722,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":2319,"price":86.3929,"value":200345.1351,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.005 - $86.72, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1689539,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558721,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:22:19.000Z","date":"2021-09-03","kind":"sale","acquired":false,"shares":30068,"price":85.4663,"value":2569800.7084,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $86.00, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1691858,"source":{"system":"sec-edgar","filing":"0000899243-21-037776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037776/doc4.xml","form_type":"4"}},{"id":2558720,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":23316,"price":86.3381,"value":2013059.1396,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.01 - $86.83, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1721926,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558719,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":28449,"price":85.418,"value":2430056.682,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $86.00, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1745242,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558718,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":11863,"price":88.585,"value":1050883.855,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $88.29 - $89.09, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1773691,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558717,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":19275,"price":87.8644,"value":1693586.31,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $87.28 - $88.28, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1785554,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558716,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":29478,"price":86.7917,"value":2558445.7326,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.275 - $87.275, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1804829,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558715,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":18821,"price":85.6652,"value":1612304.7292,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.27 - $86.27, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1834307,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558714,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":12189,"price":86.2137,"value":1050858.7893,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.00 - $86.87, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1853128,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558713,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:19:31.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":47166,"price":85.3855,"value":4027292.493,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $85.995, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1865317,"source":{"system":"sec-edgar","filing":"0000899243-21-037775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037775/doc4.xml","form_type":"4"}},{"id":2558712,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":1181,"price":88.2226,"value":104190.8906,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $88.19 - $88.33, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1912483,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558711,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":7581,"price":87.5081,"value":663398.9061,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $87.01 - $87.99, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1913664,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558710,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":25469,"price":86.3997,"value":2200513.9593,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.01 - $86.965, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1921245,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558709,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":24607,"price":85.1934,"value":2096353.9938,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $85.995, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1946714,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558708,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":2371,"price":86.0553,"value":204037.1163,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.01 - $86.16, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1971321,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558707,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":42655,"price":85.3807,"value":3641913.7585,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $85.98, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1973692,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558706,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:18:30.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":11712,"price":85.1238,"value":996969.9456,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $85.46, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2016347,"source":{"system":"sec-edgar","filing":"0000899243-21-037773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037773/doc4.xml","form_type":"4"}},{"id":2558705,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:16:49.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":14267,"price":85.0315,"value":1213144.4105,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $85.00 - $85.44, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2028059,"source":{"system":"sec-edgar","filing":"0000899243-21-037770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037770/doc4.xml","form_type":"4"}},{"id":2558704,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:16:49.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":4635,"price":87.0803,"value":403617.1905,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $87.01 - $87.20, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2042326,"source":{"system":"sec-edgar","filing":"0000899243-21-037770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037770/doc4.xml","form_type":"4"}},{"id":2558703,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:16:49.000Z","date":"2021-08-24","kind":"sale","acquired":false,"shares":4568,"price":86.9529,"value":397200.8472,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $86.00 - $87.00, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2046961,"source":{"system":"sec-edgar","filing":"0000899243-21-037770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037770/doc4.xml","form_type":"4"}},{"id":2558702,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T14:16:49.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":1599,"price":88.01,"value":140727.99,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $88.00 - $88.065, inclusive.  The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Canaan IX L.P.  The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P.  The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2051529,"source":{"system":"sec-edgar","filing":"0000899243-21-037770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924321037770/doc4.xml","form_type":"4"}},{"id":2614965,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2021-08-04T21:50:43.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":13440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to the underlying shares of Common Stock on the earlier of July 28, 2022 and the date of the first annual meeting of stockholders of the Issuer following the closing of its initial public offering. The option expires on July 28, 2031."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The option vests as to the underlying shares of Common Stock on the earlier of July 28, 2022 and the date of the first annual meeting of stockholders of the Issuer following the closing of its initial public offering. The option expires on July 28, 2031."}],"balance_after":13440,"derivative":{"exercise_price":13,"underlying":"Common Stock","underlying_shares":13440},"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2614964,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Units","published_at":"2021-08-04T21:50:43.000Z","date":"2021-07-28","kind":"other","acquired":false,"shares":4315676,"ownership":{"direct":false,"nature":"Canaan XI L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Prior to the effectiveness of the Plan of Liquidation, the Preferred Units were convertible into shares of common units of Rallybio Holdings, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan XI L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC (\"Canaan XI\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":677755},"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2614963,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Preferred Units","published_at":"2021-08-04T21:50:43.000Z","date":"2021-07-28","kind":"other","acquired":false,"shares":8742654,"ownership":{"direct":false,"nature":"Canaan XI L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Prior to the effectiveness of the Plan of Liquidation, the Preferred Units were convertible into shares of common units of Rallybio Holdings, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan XI L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC (\"Canaan XI\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1372990},"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2614962,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Preferred Units","published_at":"2021-08-04T21:50:43.000Z","date":"2021-07-28","kind":"other","acquired":false,"shares":1795946,"ownership":{"direct":false,"nature":"Canaan XI L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Prior to the effectiveness of the Plan of Liquidation, the Preferred Units were convertible into shares of common units of Rallybio Holdings, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan XI L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC (\"Canaan XI\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":282044},"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2614961,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-04T21:50:43.000Z","date":"2021-08-02","kind":"purchase","acquired":true,"shares":76923,"price":13,"value":999999.0,"ownership":{"direct":false,"nature":"Canaan XI L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan XI L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC (\"Canaan XI\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI."}],"balance_after":2409712,"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2614960,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-04T21:50:43.000Z","date":"2021-07-28","kind":"other","acquired":true,"shares":2332789,"ownership":{"direct":false,"nature":"Canaan XI L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 Preferred Units, Series A-2 Preferred Units and Series B Preferred Units (collectively, the \"Preferred Units\") reported herein were preferred units of Rallybio Holdings, LLC.  The shares of common stock of the Issuer were received on July 28, 2021 pursuant to the Plan of Liquidation and Dissolution, dated July 28, 2021, among Rallybio Holdings, LLC and its members (the \"Plan of Liquidation\"). Pursuant to the Plan of Liquidation, the holders of Preferred Units received approximately 6.37 shares of common stock of the Issuer for each Preferred Unit. Rallybio Holdings, LLC was subsequently dissolved. The Preferred Units had no expiration date prior to the liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan XI L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners XI LLC (\"Canaan XI\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan XI. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan XI."}],"balance_after":2332789,"source":{"system":"sec-edgar","filing":"0000899243-21-031633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924321031633/doc4.xml","form_type":"4"}},{"id":2665902,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T18:23:10.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":21.66,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-21-012238","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761921012238/doc1.xml","form_type":"4"}},{"id":2673629,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-10T20:00:20.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":7511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":7511,"derivative":{"exercise_price":78.53,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":7511},"source":{"system":"sec-edgar","filing":"0001209191-21-039672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919121039672/doc4.xml","form_type":"4"}},{"id":3104120,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T17:00:12.000Z","date":"2020-06-17","kind":"purchase","acquired":true,"shares":2000,"price":30.2599,"value":60519.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares received by the Reporting Person in a prior distribution."}],"balance_after":79546,"source":{"system":"sec-edgar","filing":"0001209191-20-037980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120037980/doc4.xml","form_type":"4"}},{"id":3105222,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T16:42:32.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":12.84,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-20-012375","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761920012375/doc1.xml","form_type":"4"}},{"id":3121846,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-04T21:00:23.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option award was granted on June 3, 2020. The shares underlying the award shall vest in full on June 3, 2021 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":12000,"derivative":{"exercise_price":33.57,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-034590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120034590/doc4.xml","form_type":"4"}},{"id":3121845,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-04T21:00:23.000Z","date":"2020-06-02","kind":"purchase","acquired":true,"shares":3000,"price":32.3,"value":96900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.20 to $32.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares received by the Reporting Person in a prior distribution."}],"balance_after":77546,"source":{"system":"sec-edgar","filing":"0001209191-20-034590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120034590/doc4.xml","form_type":"4"}},{"id":3134906,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-26T19:05:40.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":12923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option award was granted on May 23, 2019 and the shares underlying the award vested in full on May 23, 2020."}],"balance_after":0,"derivative":{"exercise_price":22.06,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":12923},"source":{"system":"sec-edgar","filing":"0001209191-20-032172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120032172/doc4.xml","form_type":"4"}},{"id":3134905,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T19:05:40.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":12923,"price":22.06,"value":285081.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares received by the Reporting Person in a prior distribution."}],"balance_after":74546,"source":{"system":"sec-edgar","filing":"0001209191-20-032172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120032172/doc4.xml","form_type":"4"}},{"id":3197728,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-23T19:01:20.000Z","date":"2020-03-20","kind":"purchase","acquired":true,"shares":2500,"price":40,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares received by the Reporting Person in a prior distribution."}],"balance_after":61623,"source":{"system":"sec-edgar","filing":"0001209191-20-020734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000120919120020734/doc4.xml","form_type":"4"}},{"id":3335036,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-19T19:07:02.000Z","date":"2019-09-24","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":9.15,"expiration_date":"2029-09-23","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-19-023454","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919023454/doc1.xml","form_type":"4"}},{"id":3487495,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T20:21:08.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 13, 2020."}],"balance_after":22000,"derivative":{"exercise_price":15.57,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001123292-19-000888","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000888/edgar.xml","form_type":"4"}},{"id":3510075,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-28T17:17:09.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":12923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on May 23, 2019. The shares underlying the award shall vest in full on May 23, 2020 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":12923,"derivative":{"exercise_price":22.06,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":12923},"source":{"system":"sec-edgar","filing":"0000899243-19-014885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924319014885/doc4.xml","form_type":"4"}},{"id":3510073,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-05-28T16:56:41.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":602549,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":602549},"source":{"system":"sec-edgar","filing":"0001567619-19-012238","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919012238/doc1.xml","form_type":"4"}},{"id":3510072,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-05-28T16:56:41.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":1658164,"ownership":{"direct":false,"nature":"See foonote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1658164},"source":{"system":"sec-edgar","filing":"0001567619-19-012238","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919012238/doc1.xml","form_type":"4"}},{"id":3510071,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T16:56:41.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":400000,"price":10,"value":4000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":2660713,"source":{"system":"sec-edgar","filing":"0001567619-19-012238","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919012238/doc1.xml","form_type":"4"}},{"id":3510070,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T16:56:41.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":602549,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series B Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":2260713,"source":{"system":"sec-edgar","filing":"0001567619-19-012238","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919012238/doc1.xml","form_type":"4"}},{"id":3510069,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T16:56:41.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":1658164,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock was automatically converted on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects a 1-for-10.2564 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person is a manager and member of Canaan X. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":1658164,"source":{"system":"sec-edgar","filing":"0001567619-19-012238","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000156761919012238/doc1.xml","form_type":"4"}},{"id":3529522,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":2296605,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":285867},"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529521,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-3 Preferred Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":5861455,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":729599},"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529520,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":5970000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":743110},"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529519,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":3582000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":445866},"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529518,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":50000,"price":15,"value":750000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":2254442,"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529517,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":285867,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":2204442,"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529516,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":729599,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":1918575,"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529515,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":743110,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":1188976,"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3529514,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:33:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":445866,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Canaan X L.P. (the \"Canaan Fund\"). The sole general partner of the Canaan Fund is Canaan Partners X LLC (\"Canaan X\", and together with the Canaan Fund, the \"Canaan Entities\"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors.  The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X."}],"balance_after":445866,"source":{"system":"sec-edgar","filing":"0001123292-19-000752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000112329219000752/edgar.xml","form_type":"4"}},{"id":3571764,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T17:11:24.000Z","date":"2019-03-28","kind":"purchase","acquired":true,"shares":3500,"price":14.6885,"value":51409.75,"ownership":{"direct":true},"balance_after":58898,"source":{"system":"sec-edgar","filing":"0000899243-19-009401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924319009401/doc4.xml","form_type":"4"}},{"id":3798221,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-10-03T17:25:34.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":2209833,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":679948},"source":{"system":"sec-edgar","filing":"0000899243-18-026078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924318026078/doc4.xml","form_type":"4"}},{"id":3798220,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-10-03T17:25:34.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":4462837,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1373180},"source":{"system":"sec-edgar","filing":"0000899243-18-026078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924318026078/doc4.xml","form_type":"4"}},{"id":3798219,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-10-03T17:25:34.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":9543387,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2936426},"source":{"system":"sec-edgar","filing":"0000899243-18-026078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924318026078/doc4.xml","form_type":"4"}},{"id":3798218,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T17:25:34.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":4989554,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2018, the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":4989554,"source":{"system":"sec-edgar","filing":"0000899243-18-026078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924318026078/doc4.xml","form_type":"4"}},{"id":3798217,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T17:25:34.000Z","date":"2018-10-01","kind":"purchase","acquired":true,"shares":4000,"price":16,"value":64000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering."}],"balance_after":55398,"source":{"system":"sec-edgar","filing":"0000899243-18-026078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000089924318026078/doc4.xml","form_type":"4"}},{"id":4536877,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-01T14:35:01.000Z","date":"2016-11-29","kind":"sale","acquired":false,"shares":22086,"price":11.1839,"value":247007.6154,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.06 - $11.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3244381,"source":{"system":"sec-edgar","filing":"0001140361-16-088355","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116088355/doc1.xml","form_type":"4"}},{"id":4540960,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T17:50:13.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":20840,"price":11.3312,"value":236142.208,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.11 - $11.69 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3666467,"source":{"system":"sec-edgar","filing":"0001140361-16-087978","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087978/doc1.xml","form_type":"4"}},{"id":4540959,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T17:50:13.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":6729,"price":11.7909,"value":79340.9661,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.67 - $12.07 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3687307,"source":{"system":"sec-edgar","filing":"0001140361-16-087978","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087978/doc1.xml","form_type":"4"}},{"id":4540958,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T17:50:13.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":10890,"price":11.8385,"value":128921.265,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.3950 - $12.05, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3694036,"source":{"system":"sec-edgar","filing":"0001140361-16-087978","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087978/doc1.xml","form_type":"4"}},{"id":4544707,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T19:01:00.000Z","date":"2016-11-22","kind":"sale","acquired":false,"shares":42550,"price":11.7057,"value":498077.535,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.56 - $11.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3704926,"source":{"system":"sec-edgar","filing":"0001140361-16-087649","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087649/doc1.xml","form_type":"4"}},{"id":4546942,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T18:56:49.000Z","date":"2016-11-21","kind":"sale","acquired":false,"shares":13548,"price":11.7202,"value":158785.2696,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 - $11.835, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3747476,"source":{"system":"sec-edgar","filing":"0001140361-16-087469","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087469/doc1.xml","form_type":"4"}},{"id":4546941,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T18:56:49.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":12805,"price":11.6427,"value":149084.7735,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.48 - $11.73, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3761024,"source":{"system":"sec-edgar","filing":"0001140361-16-087469","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087469/doc1.xml","form_type":"4"}},{"id":4546940,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T18:56:49.000Z","date":"2016-11-17","kind":"sale","acquired":false,"shares":18971,"price":11.5027,"value":218217.7217,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.02 - $11.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3773829,"source":{"system":"sec-edgar","filing":"0001140361-16-087469","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087469/doc1.xml","form_type":"4"}},{"id":4552638,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-16T19:33:24.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":18517,"price":11.5544,"value":213952.8248,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.24 - $11.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3792800,"source":{"system":"sec-edgar","filing":"0001140361-16-087008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087008/doc1.xml","form_type":"4"}},{"id":4552637,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-16T19:33:24.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":33064,"price":11.477,"value":379475.528,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 - $11.60, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3811317,"source":{"system":"sec-edgar","filing":"0001140361-16-087008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116087008/doc1.xml","form_type":"4"}},{"id":4557465,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T17:41:38.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":23744,"price":11.2052,"value":266056.2688,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3844381,"source":{"system":"sec-edgar","filing":"0001140361-16-086602","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116086602/doc1.xml","form_type":"4"}},{"id":4557464,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T17:41:38.000Z","date":"2016-11-11","kind":"sale","acquired":false,"shares":35391,"price":11.2023,"value":396460.5993,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.44, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3868125,"source":{"system":"sec-edgar","filing":"0001140361-16-086602","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116086602/doc1.xml","form_type":"4"}},{"id":4557463,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-14T17:41:38.000Z","date":"2016-11-10","kind":"sale","acquired":false,"shares":27135,"price":11.0702,"value":300389.877,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.24, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3903516,"source":{"system":"sec-edgar","filing":"0001140361-16-086602","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116086602/doc1.xml","form_type":"4"}},{"id":4560482,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":112510,"kind":"person","name":"SHANNON TIMOTHY M","position":1,"cik":"0001207114","reported_name":"SHANNON TIMOTHY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T16:41:03.000Z","date":"2016-11-09","kind":"sale","acquired":false,"shares":13730,"price":11.0341,"value":151498.193,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.15, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3930651,"source":{"system":"sec-edgar","filing":"0001140361-16-085852","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207114/000114036116085852/doc1.xml","form_type":"4"}}]}